GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » EV-to-FCF

Eusol Biotech Co (ROCO:6652) EV-to-FCF : -21.50 (As of May. 31, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Eusol Biotech Co's Enterprise Value is NT$925.19 Mil. Eusol Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-43.03 Mil. Therefore, Eusol Biotech Co's EV-to-FCF for today is -21.50.

The historical rank and industry rank for Eusol Biotech Co's EV-to-FCF or its related term are showing as below:

ROCO:6652' s EV-to-FCF Range Over the Past 10 Years
Min: -19.62   Med: -5.36   Max: -1.83
Current: -19.62

During the past 9 years, the highest EV-to-FCF of Eusol Biotech Co was -1.83. The lowest was -19.62. And the median was -5.36.

ROCO:6652's EV-to-FCF is ranked worse than
100% of 382 companies
in the Biotechnology industry
Industry Median: 7.97 vs ROCO:6652: -19.62

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-31), Eusol Biotech Co's stock price is NT$9.49. Eusol Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-0.380. Therefore, Eusol Biotech Co's PE Ratio for today is At Loss.


Eusol Biotech Co EV-to-FCF Historical Data

The historical data trend for Eusol Biotech Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eusol Biotech Co EV-to-FCF Chart

Eusol Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -24.47 -33.63 -19.60 -13.92 -22.84

Eusol Biotech Co Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.60 - -13.92 - -22.84

Competitive Comparison of Eusol Biotech Co's EV-to-FCF

For the Biotechnology subindustry, Eusol Biotech Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eusol Biotech Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eusol Biotech Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Eusol Biotech Co's EV-to-FCF falls into.



Eusol Biotech Co EV-to-FCF Calculation

Eusol Biotech Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=925.192/-43.031
=-21.50

Eusol Biotech Co's current Enterprise Value is NT$925.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eusol Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-43.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eusol Biotech Co  (ROCO:6652) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Eusol Biotech Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=9.49/-0.380
=At Loss

Eusol Biotech Co's share price for today is NT$9.49.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eusol Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-0.380.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Eusol Biotech Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Eusol Biotech Co (ROCO:6652) Business Description

Traded in Other Exchanges
N/A
Address
Minsheng E. Road, 6th Floor, No.135, Sec.3, Songshan District, Taipei, TWN, 10546
Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co (ROCO:6652) Headlines

No Headlines